April 9 (Reuters) - A U.S. district court has entered
into what is known as a consent decree to restrict the
production and sale of Philips' new sleep apnea
machines and other devices at several facilities in the country
until certain requirements are met, the U.S. Food and Drug
Administration said on Tuesday.